Albumin-based nanocarriers loaded with novel Zn(II)-thiosemicarbazone compounds chart a new path for precision breast cancer therapy
 
Yazarlar (6)
Ferdane Danişman-Kalindemirtaş Erzincan Binali Yıldırım Üniversitesi, Türkiye
Doç. Dr. Dilşad ÖZERKAN Kastamonu Üniversitesi, Türkiye
Prof. Dr. Ishak Afşin Kariper Erciyes Üniversitesi, Türkiye
Gökçe Erdemir Cilasun Biruni Üniversitesi, Türkiye
Bahri Ülküseven Istanbul University-Cerrahpasa, Türkiye
Serap Erdem-Kuruca İstanbul Atlas Üniversitesi, Türkiye
Makale Türü Özgün Makale (SSCI, AHCI, SCI, SCI-Exp dergilerinde yayınlanan tam makale)
Dergi Adı Anti Cancer Drugs (Q3)
Dergi ISSN 0959-4973 Wos Dergi Scopus Dergi
Dergi Tarandığı Indeksler SCI-Expanded
Makale Dili Türkçe Basım Tarihi 01-2025
Cilt / Sayı / Sayfa 36 / 3 / 208–219 DOI 10.1097/CAD.0000000000001679
Makale Linki https://doi.org/10.1097/cad.0000000000001679
Özet
This study explores the therapeutic potential of albumin-bound Zn (II)-thiosemicarbazone compounds (Alb-ZnTcA, Alb-ZnTcB) against breast cancer cells. Previous research indicates that these compounds hinder cancer cell proliferation by blocking DNA synthesis, promoting oxidative stress to induce apoptosis, and disrupting the cell cycle to inhibit cellular division. This study focuses on the loading and characterization of these potentially chemically unstable compounds on bovine serum albumin-based nanocarriers. Accordingly, unlike previous studies using albumin nanoparticles, in this study, ultraviolet light was used to precisely bind the therapeutic agent to albumin during the integration of thiosemicarbazones, achieving controlled nanoparticle size to control nanoparticle size. The mean diameter of Alb-ZnTcA nanoparticles was 32 nm, while Alb-ZnTcB exhibited an average diameter of 43 nm. Notably, Alb …
Anahtar Kelimeler
breast cancer treatment | nanoparticles | research & development | thiosemicarbazone-bovine serum albumin | thiosemicarbazones | zinc
BM Sürdürülebilir Kalkınma Amaçları
Atıf Sayıları
Web of Science 3
Scopus 3
Google Scholar 4
Albumin-based nanocarriers loaded with novel Zn(II)-thiosemicarbazone compounds chart a new path for precision breast cancer therapy

Paylaş